Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Presentation entities : Jaguar health, inc. save search
Jaguar Health Shares Presentation Replay Link from September 11-13, 2023 H.C. Wainwright Annual Global Investment Conference
Published: 2023-09-14 (Crawled : 12:30) - jaguarhealth.gcs-web.com
JAGX | $0.109 20.71% 17.16% 110M
|
Health Technology
|
| O: 3.17%
H: 1.51%
C: -5.23%
conference health presentation global
Jaguar Health Shares Replay Link for September 7, 2023 Presentation at Emerging Growth Conference
Published: 2023-09-11 (Crawled : 12:30) - jaguarhealth.gcs-web.com
JAGX | $0.109 20.71% 17.16% 110M
|
Health Technology
|
| O: 0.03%
H: 0.0%
C: -2.94%
conference health presentation growth
Jaguar Health Provides Updates on Presentation at the World Congress of Gastroenterology About Crofelemer for Pediatric Short Bowel Syndrome (SBS) and Congenital Diarrheal Disorders (CDD) by Third-Party Investigator
Published: 2022-12-19 (Crawled : 14:00) - jaguarhealth.gcs-web.com
JAGX | $0.109 20.71% 17.16% 110M
|
Health Technology
|
| O: 2.56%
H: 1.66%
C: -6.75%
health crofelemer presentation
Jaguar Health Announces Online Availability of a Presentation on Short Bowel Syndrome (SBS) by Dr. Mohamad Miqdady at Elite Ped-GI Congress in Abu Dhabi
Published: 2022-06-22 (Crawled : 13:00) - jaguarhealth.gcs-web.com
JAGX | $0.109 20.71% 17.16% 110M
|
Health Technology
|
| O: -1.81%
H: 4.34%
C: -0.41%
health presentation
Jaguar Health Announces Presentation of an Investigator-initiated Evaluation of Crofelemer for a Severe Congenital Diarrheal Disorder at 2022 Digestive Disease Week
Published: 2022-05-24 (Crawled : 13:20) - biospace.com/
JAGX | $0.109 20.71% 17.16% 110M
|
Health Technology
|
| O: -4.85%
H: 0.0%
C: 0.0%
disease health crofelemer week presentation
Jaguar Health Announces the Presentation of Findings from the Investigator-Initiated Phase 2 HALT-D Study of Crofelemer for Prevention of Chemotherapy-Induced Diarrhea (CID) in Breast Cancer Patients at San Antonio Breast Cancer Symposium (SABCS 2021)
Published: 2021-12-10 (Crawled : 16:20) - jaguarhealth.gcs-web.com
JAGX | $0.109 20.71% 17.16% 110M
|
Health Technology
|
| O: 5.22%
H: 0.0%
C: 0.0%
health phase 2 symposium sabcs presentation diarrhea therapy cancer breast cancer initiated crofelemer
Jaguar Health Announces the Presentation of Findings from the Investigator-Initiated Phase 2 HALT-D Study of Crofelemer for Prevention of Chemotherapy-Induced Diarrhea
Published: 2021-12-10 (Crawled : 15:00) - biospace.com/
JAGX | $0.109 20.71% 17.16% 110M
|
Health Technology
|
| O: 5.22%
H: 0.0%
C: 0.0%
health phase 2 presentation diarrhea therapy initiated crofelemer
Jaguar Health Subsidiary Napo Pharmaceuticals Submits Late-Breaking Abstract for Consideration for Presentation at the 2021 IDWeek Annual Meeting
Published: 2021-08-23 (Crawled : 13:00) - jaguarhealth.gcs-web.com
JAGX | $0.109 20.71% 17.16% 110M
|
Health Technology
|
| O: -0.3%
H: 4.32%
C: 3.42%
presentation
Jaguar Health and Napo Pharmaceuticals Announce Title of Abstract for Poster Presentation at the American Society of Clinical Oncology 2021 Annual Meeting
Published: 2021-04-29 (Crawled : 13:00) - biospace.com/
JAGX | $0.109 20.71% 17.16% 110M
|
Health Technology
|
| O: -4.22%
H: 5.03%
C: -4.4%
presentation
Jaguar Health and Napo Pharmaceuticals Announce Title of Abstract Regarding Patient Outcomes Associated with Cancer Therapy-Related Diarrhea Accepted for Poster Presentation at the American Society of Clinical Oncology 2021 Annual Meeting
Published: 2021-04-29 (Crawled : 12:15) - jaguarhealth.gcs-web.com
JAGX | $0.109 20.71% 17.16% 110M
|
Health Technology
|
| O: -4.22%
H: 5.03%
C: -4.4%
presentation tcom diarrhea therapy cancer
Jaguar Health and Napo Pharmaceuticals Announce Acceptance of Abstract for Poster Presentation at American Society of Clinical Oncology Annual Meeting
Published: 2021-04-14 (Crawled : 13:00) - biospace.com/
JAGX | $0.109 20.71% 17.16% 110M
|
Health Technology
|
| O: -1.18%
H: 1.8%
C: 1.2%
presentation
Gainers vs Losers
| 49% | 51% |
Top 10 Gainers
KAVL | $6.275 135.02% 57.45% 44M
|
Wholesale Trade
PXMD | $0.7375 79.09% 44.16% 4.5M
|
Health Technology
DYNT | $0.371 -5.12% 43.09% 3.3M
|
Health Technology
LGVN P 3 d | $2.94 73.96% 42.52% 57M
|
HUBC | $1.94 49.23% 32.99% 73M
|
n/a
SPCB | $0.4044 46.52% 31.75% 130M
|
Electronic Technology
ONVO | $1.34 32.66% 24.62% 54M
|
Health Technology
OMQS | $0.6869 32.1% 24.3% 3.6M
|
Professional, Scientific, and T...
SNPO | $10.555 29.67% 22.88% 4M
|
AMBI | $3.72 -26.77% 21.77% 9.8K
|
n/a
Your saved searches
Save your searches and get alerts when important news are released.